Eyenovia Announces 1-for-80 Reverse Stock Split

Core Viewpoint - Eyenovia, Inc. has announced a 1-for-80 reverse stock split to regain compliance with Nasdaq's minimum bid price requirement while evaluating strategic alternatives [1][2]. Group 1: Reverse Stock Split Details - The reverse stock split will reduce the number of outstanding shares from approximately 167.5 million to about 2.1 million [2]. - Fractional shares will not be issued; stockholders entitled to fractional shares will receive cash payments instead [2]. - The reverse stock split will not affect stockholders' percentage ownership interests, except for cash payments for fractional shares [2]. Group 2: Company Overview - Eyenovia, Inc. focuses on developing the Optejet topical ophthalmic medication dispensing platform, which aims to improve treatment options for chronic front-of-the-eye diseases [3].